Sun Pharma Reports 26 Profit Surge in Q4 FY2026 Proposes 5 Final Dividend Stock Market Rally Gains Momentum as Earnings Season Heats Up Iran Deal News Looms Zuckerbergs Leaked AllHands Comment Signals Metas Shift From Headcount to AI Compute Ebola Risk in DR Congo Raises Concerns for Regional Markets and Supply Chains Live Music Spending Sees Shift as Consumers Become More Intentional With Concert Choices Fed Dissenters Explain No Votes Citing Disagreement Over Rate Cut Signal ESS Q1 2026 Earnings EPS Beat Lifts Shares Amid Steady Apartment Demand CMPR Q1 2026 Earnings Massive EPS Beat Surprises Market MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues MTH Q1 2026 Earnings Earnings Miss Estimates Despite Modest Stock Uptick WHLRD Q2 2024 Earnings Preferred Dividend Coverage Remains Robust Amid Limited Market Visibility VTVT Q1 2026 Earnings Massive EPS Beat Driven by OneTime Items Stock Declines HP Inc HPQ Rallies 182 Nears Resistance at 2612 Atrium Therapeutics Inc RNA Holds Steady Near Resistance as Momentum Builds Weyco Group Holds Steady Near Support as Technicals Suggest Consolidation LiqTech International LIQT Edges Lower as Stock Tests Key Support Near 171 American Homes 4 Rent AMH Slides Slightly Amidst Sector Headwinds Key Levels in Focus Analog Devices Projects Q3 Revenue Could Surpass Market Expectations CDP Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Modest Stock Decline IDEX Corporation IEX Edges Higher Amidst Consolidation Key Levels to Watch NGG Q1 2026 Earnings EPS Falls Short of Estimates as Utility Giants Shares Edge Higher Hecla Mining Q1 2026 Earnings EPS Falls Short of Expectations Amid Cost Pressures ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline PNBK Q1 2019 Earnings EPS Misses Estimates by Over 70 as Stock Declines TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense KMPR Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Challenges Persist PLRX Q1 2026 Earnings Narrowerthanexpected loss as clinical pipeline progresses